GLMP promotes EGFR-TKI resistance by activating autophagy and RhoA pathway in non-small cell lung cancer

Xiao Liang, Jiali Xu, Suhui Shu, Wei Lv, Dandan Yin, Sunan Miao, Xiyi Lu, Chen Zhang, Xinyin Liu, Jiali Dai, Jun Li, Weibing Wu, Erbao Zhang, Renhua Guo · 2025

Read GLMP promotes EGFR-TKI resistance by activating autophagy and RhoA pathway in non-small cell lung cancer by Xiao Liang, Jiali Xu, Suhui Shu, Wei Lv, Dandan Yin, Sunan Miao, Xiyi Lu, Chen Zhang, Xinyin Liu, Jiali Dai, Jun Li, Weibing Wu, Erbao Zhang, Renhua Guo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12678831.txt.

Description

Resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) restricts the long-term efficacy of treatment in patients with lung cancer. Here, we report that the EGFR-TKI resistance mechanism is mediated by lysosome-related regulation. The overexpression of glycosylated lysosomal membrane protein (GLMP), a lysosomal membrane protein, promotes resistance to Osimertinib both in vitro and in vivo.

Catalog record

CREATORXiao Liang, Jiali Xu, Suhui Shu, Wei Lv, Dandan Yin, Sunan Miao, Xiyi Lu, Chen Zhang, Xinyin Liu, Jiali Dai, Jun Li, Weibing Wu, Erbao Zhang, Renhua Guo
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12678831

Browse the full library · About the Tower of Babel